Total Visits
| Views | |
|---|---|
| Safety, ... | 123 |
Total Visits Per Month
| June 2025 | July 2025 | August 2025 | September 2025 | October 2025 | November 2025 | December 2025 | |
|---|---|---|---|---|---|---|---|
| Safety, ... | 11 | 10 | 10 | 0 | 5 | 13 | 0 |
File Visits
| Views | |
|---|---|
| safety_pharmacokinetics_pharmacodynamics_antitumor_activity_sar439459_a_tgfb_inhibitor_monotherapy_combination_cemiplimab_patients_advanced_solid_tumors_findings_a_phase_1_1b_study_2024.pdf | 72 |
Top country views
| Views | |
|---|---|
| United States | 34 |
| Singapore | 20 |
| Ireland | 15 |
| Hong Kong | 12 |
| China | 10 |
| Brazil | 8 |
| Germany | 8 |
| Austria | 4 |
| Spain | 4 |
| Mexico | 2 |
Top cities views
| Views | |
|---|---|
| Singapore | 16 |
| Dublin | 15 |
| Hong Kong | 11 |
| Ashburn | 9 |
| Beijing | 9 |
| Düsseldorf | 6 |
| Barcelona | 4 |
| Mexico City | 2 |
| Vienna | 2 |
| Almont | 1 |



